Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

>> Preview...
Free White Paper

>>NEW! Download now...

Anhui Anke Buys Company with a Hepatitis B Drug

publication date: Jun 10, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Anhui Anke Biotechnology paid 7 million RMB ($1 million) for a 70% stake in Zhejiang Fuwei Pharmaceutical. Fuwei’s major product is adefovir dipivoxil, an oral nucleotide analog reverse transcriptase inhibitor (ntRTI), used to treat hepatitis B. More details...

Stock Symbol: (SZEX: 300009)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
  Subscribe 
Forgot password?
>> Login help...
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events


BioPacific Conference 2012
June 2, 2012
California, USA

  China Forum 2012
  November 11, 2012
Hamburg, Germany

>>More details...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners